Loading…
for educational and safety purposes
MT-2 and PT-141 both come up in the same conversations; they overlap on Libido. MT-2: MT-2 (Melanotan II) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone that acts as a non-selective agonist at melanocortin receptors, most notably MC1R and MC4R. PT-141: PT-141 (bremelanotide) is a first-in-class libido peptide that works in the brain rather than the bloodstream, activating melanocortin pathways to spark sexual desire and arousal in both women and men [1][2].
MT-2 (Melanotan II) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone that acts as a non-selective agonist at melanocortin receptors, most notably MC1R and MC4R. Through MC1R activation it stimulates melanogenesis, producing durable skin darkening with reduced ultraviolet exposure, while central MC4R activation drives pro-erectile and pro-sexual effects that were demonstrated in early human trials of erectile dysfunction and later informed development of the approved drug bremelanotide. Preclinical work has additionally characterized its capacity to suppress food intake, reduce adiposity and improve insulin sensitivity, promote peripheral nerve regeneration and neuroprotection, and stimulate central oxytocin pathways; the last of these underlies reports of rescued social behavior in a rodent model of autism. MT-2 remains an unapproved research compound, and its unregulated recreational use has been linked to adverse events including nausea, rhabdomyolysis, renal injury and case reports of melanoma arising in heavily pigmented skin.
PT-141 (bremelanotide) is a first-in-class libido peptide that works in the brain rather than the bloodstream, activating melanocortin pathways to spark sexual desire and arousal in both women and men [1][2]. Unlike erectile-focused drugs that act on blood vessels, it targets the central circuits of desire, and it is the active ingredient in Vyleesi, approved by the FDA in 2019 for hypoactive sexual desire disorder in premenopausal women [2][3]. A synthetic analog of the hormone alpha-MSH, PT-141 is prized as the rare desire-boosting agent backed by large randomized clinical trials [3][4].
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
activates
non-selective agonist
activates
agonist
activates
agonist
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: MT-2 is currently listed by more trusted vendors (7), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.